arrow
T

Theresa L. Werner

slc
H指数:34
被引数:5,972

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort

探索卵巢癌中与生存相关的转录组亚型:使用来自临床 trial 研究队列的石蜡包埋组织 RNAseq 数据

2026-03-190
OAAI
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study

通过分子改变选择的实体瘤患者的sitratinib: Ib期研究的结果

2024-11-080
OAAI
Ovarian Cancer/Fallopian Tube Cancer/Primary PeritonealCancer, Version 3.2024Featured Updates to the NCCN Guidelines

卵巢癌/输卵管癌/原发性腹膜癌,版本3.2024 NCCN指南重点更新

2024-10-0115
PRE
Safety and efficacy of three PARP inhibitors (PARPi) combined with the ataxia telangiectasia- and Rad3-related kinase inhibitor (ATRi) camonsertib in patients (pts) with solid tumors harboring DNA damage response (DDR) alterations
2023-04-140
PRE
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker
2021-05-0736
OAAI
Ovarian Cancer, Version 2.2020
2021-02-01447
OA
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
2019-12-19655
OAAI